Search

Your search keyword '"Florian P. Maurer"' showing total 119 results

Search Constraints

Start Over You searched for: Author "Florian P. Maurer" Remove constraint Author: "Florian P. Maurer"
119 results on '"Florian P. Maurer"'

Search Results

2. Delineating Mycobacterium abscessus population structure and transmission employing high-resolution core genome multilocus sequence typing

3. Rapid molecular diagnostics of tuberculosis resistance by targeted stool sequencing

4. Molecular Epidemiology of Mycobacterium abscessus Isolates Recovered from German Cystic Fibrosis Patients

5. Secretome characterization of clinical isolates from the Mycobacterium abscessus complex provides insight into antigenic differences

6. Sub-Lineage Specific Phenolic Glycolipid Patterns in the Mycobacterium tuberculosis Complex Lineage 1

7. The Use of Comparative Genomic Analysis for the Development of Subspecies-Specific PCR Assays for Mycobacterium abscessus

8. Two Pandemics, One Challenge—Leveraging Molecular Test Capacity of Tuberculosis Laboratories for Rapid COVID-19 Case-Finding

9. Comparative analysis of phenotypic and genotypic antibiotic susceptibility patterns in Mycobacterium avium complex

10. Phylogenetically informative mutations in genes implicated in antibiotic resistance in Mycobacterium tuberculosis complex

11. Correction: Rapid molecular diagnostics of tuberculosis resistance by targeted stool sequencing

12. Species-Specific Interferon-Gamma Release Assay for the Diagnosis of Mycobacterium abscessus Complex Infection

13. Nontuberculous Mycobacterial Pulmonary Disease from Mycobacterium hassiacum, Austria

14. Emergence of linezolid-resistance in vancomycin-resistant Enterococcus faecium ST117 associated with increased linezolid-consumption

15. ‘Those who cannot remember the past are condemned to repeat it’: Drug-susceptibility testing for bedaquiline and delamanid

16. Advances in rapid identification and susceptibility testing of bacteria in the clinical microbiology laboratory: implications for patient care and antimicrobial stewardship programs

18. Tuberkulose im Erwachsenenalter

19. Diagnostic Capacities for Multidrug-Resistant Tuberculosis in the World Health Organization European Region

20. Pretomanid-resistant tuberculosis

21. Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement

22. Novel synergies and isolate specificities in the drug interactions landscape ofMycobacterium abscessus

23. [Tuberculosis in adulthood - The Sk2-Guideline of the German Central Committee against Tuberculosis (DZK) and the German Respiratory Society (DGP) for the diagnosis and treatment of adult tuberculosis patients]

24. C25-modified rifamycin derivatives with improved activity against Mycobacterium abscessus

26. Cost of multidrug resistant tuberculosis in Germany—An update

27. Systematic rifampicin resistance errors with Xpert® MTB/RIF Ultra: implications for regulation of genotypic assays

28. Rifapentine access in Europe:growing concerns over key tuberculosis treatment component

29. Origin and Global Expansion of

30. Die neuen WHO-Empfehlungen für schnelle Diagnostik und Therapie resistenter Tuberkulose in Deutschland, Österreich und der Schweiz

31. Bedaquiline-Resistant Tuberculosis: Dark Clouds on the Horizon

32. Antibiotic Stewardship bei ambulant erworbener Pneumonie

33. Investigating resistance in clinical Mycobacterium tuberculosis complex isolates with genomic and phenotypic antimicrobial susceptibility testing: a multicentre observational study

34. The ESX-4 substrates, EsxU and EsxT, modulate Mycobacterium abscessus fitness

35. Emergence of bedaquiline resistance in a high tuberculosis burden country

36. Sub-Lineage Specific Phenolic Glycolipid Patterns in the

38. Ancient and recent differences in the intrinsic susceptibility of Mycobacterium tuberculosis complex to pretomanid

39. TREATMENT OF MYCOBACTERIOSIS CAUSED BY MYCOBACTERIUM AVIUM SSP. HOMINISSUIS IN A GROUP OF CAPTIVE LOWLAND TAPIRS (TAPIRUS TERRESTRIS)

40. Late Breaking Abstract - Therapeutic drug monitoring in a patient with very advanced XDR-TB

41. Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic model

42. Mycobacterium szulgai als Posititivkontrolle zur Detektion von Kontaminationen beim Nachweis des Mycobacterium tuberculosis-Komplexes durch eine spezifische 16S-rDNA-PCR an FFPE-Material

43. Conserved and specialized functions of Type VII secretion systems in non-tuberculous mycobacteria

44. C25-modified rifamycin derivatives with improved activity againstMycobacterium abscessus

45. Conserved and specialized functions of Type VII secretion systems in non-tuberculous mycobacteria

46. Nontuberculous Mycobacterial Pulmonary Disease from Mycobacterium hassiacum, Austria

47. What is the role of the EUCAST reference method for MIC testing of the Mycobacterium tuberculosis complex?

48. The landscape of diagnostic mycobacteriology in Germany–challenges of decentralised care

49. Rifamycin derivatives active against pathogenic rapidly-growing mycobacteria

50. Secretome characterization of clinical isolates from the Mycobacterium abscessus complex provides insight into antigenic differences

Catalog

Books, media, physical & digital resources